Comparison of the prognostic value of immunoinflammation-based biomarkers in patients with gastric cancer.

Conclusions: Compared to NLR and PLR, SII is the most significant prognostic biomarker for OS, especially in gastric cancer patients with inflammation. PMID: 32676164 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32676164?dopt=Abstract

Source: Oncotarget - July 18, 2020 Category: Cancer & Oncology Tags: Oncotarget Source Type: research